Roche Continues to be at the Top in Oncology Sales

Swiss drug maker Roche continues to be at the top of the heap in oncology sales for several years and it’s no wonder with its best selling drugs such as Avastin, Herceptin, Rituxan and Triumvirate. Roche generated revenue of over $25 billion via its cancer drugs in the previous year, which is more than twice the revenue generated by its nearest competitor Novartis. But...

Read More

FDA Awards $19 Million for 18 New Rare Disease Research Grants

The U.S. Food and Drug Administration (FDA) has awarded 18 new research grants totaling more than $19 million to enhance the development of orphan drugs for rare disease patients. The grants are intended for clinical studies evaluating the safety and effectiveness of products that could either result in, or substantially contribute to, the FDA approval of products. Since...

Read More

Sensitive Blood Test May Help Rule Out Heart Attack

WEDNESDAY Oct. 7, 2015, 2015 — A new, highly sensitive blood test may help doctors quickly rule out heart attack for almost two-thirds of people who seek emergency room treatment for chest pain, a new study suggests. Researchers said their findings could potentially reduce unnecessary hospital admissions and substantially lower health-care costs. “Until now, there...

Read More

Insight into cancer resistance in elephants could aid human treatment !!!!

They are the largest land animals in the world, weighing up to 14,000 pounds and standing up to 4 meters tall. Given their size, elephants should be highly susceptible to cancer – they have at least 100 times more cells than humans – but they rarely develop the disease. In a new study, researchers shed light on the mechanisms behind elephants’ resistance to cancer –...

Read More

HRT safe and perhaps beneficial in women treated for ovarian cancer, major trial shows

Women with the commonest type of ovarian cancer can safely take hormone replacement therapy (HRT), and it could have a beneficial effect on their survival, a long-term clinical trial reports.The 24-year, phase III international trial provides the strongest evidence yet that women with epithelial ovarian cancer – which accounts for 80-90 per cent of cases – can safely take...

Read More

Moving Beyond Price-Per-Dose In The Pharmaceutical Industry..

By Dana Goldman and Darius Lakdawalla The United States has experienced extraordinary gains in treating cardiovascular disease over the last few decades. Statins, introduced in the 1980’s, are an important part of the story. Hundreds of thousands of deaths, heart attacks, and strokes have been prevented due to lower cholesterol, and the health benefits—appropriately...

Read More